Code | Description |
---|---|
Z12.31 | Encounter for screening mammogram for malignant neoplasm of breast |
Z12.31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
The highest quality evidence suggests that breast cancer screening does not save lives, or at best, has an extremely marginal effect on mortality. In which case, that extremely small potential reduction needs to be weighed against the harms caused by false positives and also against the cost of screening.
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
ICD-9 Code V76. 12 -Other screening mammogram- Codify by AAPC.
An ICD-10-CM diagnosis code(s) should be linked to the appropriate CPT mammography code reported. The proper diagnosis code to report would be Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
When modifier 52 is appended to the screening mammography codes 77057 or G0202 and 77052, it would be assumed that the service rendered was a unilateral mammography. The unilateral mammography would be paid at a reduced rate.
Applicable To. Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
NOTE: Mammograms will not interfere with your ICD or S-ICD. However, your device could be damaged if it gets compressed in the mammogram machine. Make sure the doctor or technician knows you have an implanted device.
793.80 - Abnormal mammogram, unspecified. ICD-10-CM.
Other specified disorders of breast N64. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM N64. 89 became effective on October 1, 2021.
ICD-10 code Z12. 39 for Encounter for other screening for malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease. Type 1 Excludes. encounter for diagnostic examination-code to sign or symptom. Use Additional.
The 2022 edition of ICD-10-CM Z12.31 became effective on October 1, 2021.
Screening mam mogram for breast cancer in high risk patient with family history of breast cancer done
A procedure code is also required to confirm that the screening was performed. ICD 9 V73-V82 Special screening examinations are used for the purpose.
For Medicare services, diagnosis codes V76.11 and V76.12 must be the first listed diagnosis on all encounters for screening mammography services. However, effective Oct. 1, 2006, this requirement will change to allow the reporting of any applicable diagnosis code as a primary diagnosis on claims containing other services in addition to a screening mammography. Continue reporting diagnosis codes V76.11 and V76.12 as the first listed diagnosis codes on claims that contain only screening mammography services.
This spreads the tissue and allows for a lower X-ray dose. A screening mammogram is used to detect breast changes in women who have no signs of breast cancer.
The National Cancer Institute (NCI) guidelines for screening mammography recommend that asymptomatic women 40 years or older be screened every 1 to 2 years and women aged 50 or older be screened every 1 to 2 years.
Diagnostic mammograms are performed when there is a problem such as a breast mass, pain, discharge, etc. Code any positive findings found on the diagnostic mammogram as the first listed diagnoses. If there are no reported findings, assign the reason for the test.
Every woman is at risk for developing breast cancer, and the risk increases with age. According to the Center of Disease Control and Prevention (CDC), approximately 94 percent of breast cancers are diagnosed in women older than age 40. Mammography is the best available way to detect breast cancer early, when it is most curable.
V76.11 and V76.12 Special screening for malignant neoplasm, other screening mammography.
Report code V76.12 (Screening for malignant neoplasms, other screening mammogram) for all other screening mammography. If the patient has a personal history of breast cancer, has completed active treatment and is back to annual mammographic screening, report V76.11.
Screening Mammography: Screenings are performed on otherwise healthy individuals to look for cancer or precursors to cancer of the breasts.
Screening mammography is recommended for women age 40 and older every one to two years and younger than 40 years of age when the patient has increased risk factors for breast cancer.
In general, screening mammograms are not recommended for women under 40 years of age, in part because breast tissue tends to be more dense in younger women, making mammograms as a screening tool less effective.
Diagnostic Mammography: Diagnostic mammography includes additional x-ray views of each breast, taken from different angles and if performed digitally, may be manipulated, enlarged, or enhanced for better visualization of the abnormality found during screening mammography.
Analog or conventional mammography is when the radiologist takes an image and prints it on film for the radiologist to review on a light box.
Patient's with breast implants should still undergo screening mammograms; however, the implants can make it more difficult to see the breast tissue clearly. There is a technique that technicians should be trained in that allows them to better visualize breast tissue surrounding the implants called 'implant displacement views.' Patients with implants after mastectomy should have orders that clarify if the physician wants the reconstructed breast to be screened as well.
As shown in Table C, codes 77046 and 77047 are reported for breast MRI without contrast.
Screening mammography is performed for a person without signs or symptoms of breast disease.
Modifiers that can be used with CPT® codes 76641 or 76642 include: 1 50 – Bilateral procedure. This modifier is used to bill bilateral procedures that are performed at the same operative session. Under the Medicare physician fee schedule (MPFS), payments are adjusted to 150 percent of the unilateral payment when a service has a bilateral payment indicator assigned. 2 26 – Professional component. A physician who performs the interpretation of an ultrasound exam in the hospital outpatient setting may submit a charge for the professional component of the ultrasound service by appending this modifier to the ultrasound code. 3 TC – Technical component. This modifier is used to bill for services by the owner of the equipment to report the technical component of the service. This modifier is commonly used when the service is performed in an independent diagnostic testing facility (IDTF).
When mammography reveals an abnormal finding, a breast ultrasound may be used during a needle biopsy or as a follow-up test. A breast ultrasound alone is not considered a good breast cancer screening tool.